Federal Circuit Expands Direct Patent Infringement Liability / FDA Issues Kardashian Warning
DC Client Alert - August 19, 2015
Federal Circuit Expands Direct Patent Infringement Liability
By Scott A.M. Chambers, Ph.D. and Caroline C. Maxwell
On August 13, 2015, the Court of Appeals for the Federal Circuit, sitting en banc, made new law on multi-actor infringement in Akamai Technologies, Inc. v. Limelight Networks, Inc., expanding liability under 35 U.S.C. § 271(a). The Court's ruling reinstates a 2008 jury verdict finding Limelight liable for infringement, awarding Akamai over $45 million in damages.
FDA Issues Warning Letter for Kardashian Social Media Posts Promoting Drug
The Food and Drug Administration (FDA) has issued a warning letter to the maker of an anti-morning sickness drug endorsed by Kim Kardashian in Instagram and Twitter posts.